Abstract
HPR188 Orphan Drugs – How Will the New Proposed European Union (EU) Commission Pharmaceutical Regulation Impact Therapies for Rare Diseases?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have